BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21671383)

  • 21. Overlap of the Pitt-Hopkins and Lennox-Gastaut syndromes.
    Sulentic V; Petelin Gadze Z; Dapic Ivancic B; Mrak G; Borovecki F
    Acta Neurol Belg; 2020 Apr; 120(2):399-401. PubMed ID: 30426346
    [No Abstract]   [Full Text] [Related]  

  • 22. Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.
    Tripon F; Bogliș A; Micheu C; Streață I; Bănescu C
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32481733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
    Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
    Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging roles of TCF4 in disease and development.
    Forrest MP; Hill MJ; Quantock AJ; Martin-Rendon E; Blake DJ
    Trends Mol Med; 2014 Jun; 20(6):322-31. PubMed ID: 24594265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, cognition, and behaviour in Pitt-Hopkins syndrome.
    Van Balkom ID; Vuijk PJ; Franssens M; Hoek HW; Hennekam RC
    Dev Med Child Neurol; 2012 Oct; 54(10):925-31. PubMed ID: 22712893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitt-Hopkins syndrome in a boy with Charcot Marie Tooth disease type 1A: a rare co-occurrence of 2 genetic disorders.
    Ghosh PS; Friedman NR; Ghosh D
    J Child Neurol; 2012 Dec; 27(12):1602-6. PubMed ID: 22378661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome.
    Kalscheuer VM; Feenstra I; Van Ravenswaaij-Arts CM; Smeets DF; Menzel C; Ullmann R; Musante L; Ropers HH
    Am J Med Genet A; 2008 Aug; 146A(16):2053-9. PubMed ID: 18627065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model.
    Brockschmidt A; Filippi A; Charbel Issa P; Nelles M; Urbach H; Eter N; Driever W; Weber RG
    Hum Genet; 2011 Nov; 130(5):645-55. PubMed ID: 21544580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation.
    Forrest MP; Waite AJ; Martin-Rendon E; Blake DJ
    PLoS One; 2013; 8(8):e73169. PubMed ID: 24058414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4.
    Brockschmidt A; Todt U; Ryu S; Hoischen A; Landwehr C; Birnbaum S; Frenck W; Radlwimmer B; Lichter P; Engels H; Driever W; Kubisch C; Weber RG
    Hum Mol Genet; 2007 Jun; 16(12):1488-94. PubMed ID: 17478476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDKL5 mutations may mimic Pitt-Hopkins syndrome phenotype.
    Currò A; Doddato G; Bruttini M; Zollino M; Marangi G; Zappella M; Renieri A; Pinto AM
    Eur J Med Genet; 2021 Jan; 64(1):104102. PubMed ID: 33220470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mosaic microdeletion 18q21 as a cause of mental retardation.
    Stavropoulos DJ; MacGregor DL; Yoon G
    Eur J Med Genet; 2010; 53(6):396-9. PubMed ID: 20813211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCF4 deletions in Pitt-Hopkins Syndrome.
    Giurgea I; Missirian C; Cacciagli P; Whalen S; Fredriksen T; Gaillon T; Rankin J; Mathieu-Dramard M; Morin G; Martin-Coignard D; Dubourg C; Chabrol B; Arfi J; Giuliano F; Claude Lambert J; Philip N; Sarda P; Villard L; Goossens M; Moncla A
    Hum Mutat; 2008 Nov; 29(11):E242-51. PubMed ID: 18781613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
    Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
    Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.
    Goodspeed K; Newsom C; Morris MA; Powell C; Evans P; Golla S
    J Child Neurol; 2018 Mar; 33(3):233-244. PubMed ID: 29318938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
    Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
    J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption and deletion of the proximal part of TCF4 are associated with mild intellectual disability: About three new patients.
    Masson J; Pons L; Busa T; Missirian C; Lines M; Tevissen H; Diguet F; Rollat-Farnier PA; Lesca G; Sanlaville D; Schluth-Bolard C
    Eur J Med Genet; 2022 Apr; 65(4):104458. PubMed ID: 35189377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic variants in SOX11 mimicking Pitt-Hopkins syndrome phenotype.
    Pasquetti D; L'Erario FF; Marangi G; Panfili A; Chiurazzi P; Sonnini E; Orteschi D; Alfieri P; ; Morleo M; Nigro V; Zollino M
    Clin Genet; 2024 Jan; 105(1):81-86. PubMed ID: 37558216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCF4, schizophrenia, and Pitt-Hopkins Syndrome.
    Blake DJ; Forrest M; Chapman RM; Tinsley CL; O'Donovan MC; Owen MJ
    Schizophr Bull; 2010 May; 36(3):443-7. PubMed ID: 20421335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor 4 and its association with psychiatric disorders.
    Teixeira JR; Szeto RA; Carvalho VMA; Muotri AR; Papes F
    Transl Psychiatry; 2021 Jan; 11(1):19. PubMed ID: 33414364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.